SOPHARMA AD: Sales revenues for the first eight months of 2017

opublikowano: 2017-09-05 13:26

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załącznikĂłw:
3JR_Sales_revenues_August_2017.doc  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 65 / 2017
Date of issue: 2017-09-05
Short name of the issuer
SOPHARMA AD
Subject
Sales revenues for the first eight months of 2017
Official market - legal basis
art. 17. 1 MAR.
Unofficial market - legal basis
Contents of the report:
Sopharma AD notifies that for August 2017 the Company recorded an increase of sales revenues of 12% compared to the same month of 2016, including 12% increase of domestic sales and 12% increase of export sales.

For the first eight months of this year, revenues from sales increased by 17% compared to the same period of 2016, including 3% increase of domestic sales and a 27% increase of export sales.
Annexes
File Description
3JR Sales revenues August 2017.doc3JR Sales revenues August 2017.doc Sales revenues for the first eight months of 2017

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2017-09-05 Ognian Donev Executive director